Cingulate Inc., a company listed in the United States, has received communication from the Securities and Exchange Commission (SEC) regarding its recently filed Registration Statement on Form S-1. The SEC, in a letter dated January 18, 2024, informed Cingulate's CEO Shane Schaffer that it has not reviewed and will not review the company's registration statement, which was filed on January 12, 2024. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures. The SEC's Division of Corporation Finance, Office of Life Sciences, directed any further questions to Daniel Crawford and provided his contact information.

Cingulate Inc., a company listed in the United States, has received communication from the Securities and Exchange Commission (SEC) regarding its recently filed Registration Statement on Form S-1. The SEC, in a letter dated January 18, 2024, informed Cingulate's CEO Shane Schaffer that it has not reviewed and will not review the company's registration statement, which was filed on January 12, 2024. The SEC's letter also referenced Rules 460 and 461, which pertain to requests for acceleration of the registration process. Additionally, the SEC reminded the company and its management of their responsibility to ensure the accuracy and adequacy of their disclosures. The SEC's Division of Corporation Finance, Office of Life Sciences, directed any further questions to Daniel Crawford and provided his contact information.